Viscoli, C. M., & Ringleb, P. A. (2014). Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial. American heart journal, 168(6), . https://doi.org/10.1016/j.ahj.2014.07.016
Chicago-Zitierstil (17. Ausg.)Viscoli, Catherine M., und Peter A. Ringleb. "Pioglitazone for Secondary Prevention After Ischemic Stroke and Transient Ischemic Attack: Rationale and Design of the Insulin Resistance Intervention After Stroke Trial." American Heart Journal 168, no. 6 (2014). https://doi.org/10.1016/j.ahj.2014.07.016.
MLA-Zitierstil (9. Ausg.)Viscoli, Catherine M., und Peter A. Ringleb. "Pioglitazone for Secondary Prevention After Ischemic Stroke and Transient Ischemic Attack: Rationale and Design of the Insulin Resistance Intervention After Stroke Trial." American Heart Journal, vol. 168, no. 6, 2014, https://doi.org/10.1016/j.ahj.2014.07.016.